Over the last two decades, there have been remarkable advances in genetics, with hundreds of genes identified and validated as being associated with a high risk for autism
However, the clinical benefit of this modality has still been limited due to several defects such as adverse events, acquired drug resistance, tumor recurrence, and lack of validated biomarkers, which impel further research on mechanisms of tumor angiogenesis, the development of multiple drugs and the combination therapy to figure out how to improve the therapeutic efficacy
Err on the side of shorter storage rather than longer, and aliquot whenever possible
Lazic R, Gabric N, Dekaris I, Bosnar D, Boban-Blagaic A, Sikiric P